Extrait

This phase II trial studies how well azacitidine works in treating patients with relapsed myelodysplastic syndrome (MDS), chronic myelomonocytic leukemia (CMML), or acute myeloid leukemia (AML) who have undergone stem cell transplant. Drugs used in chemotherapy, such as azacitidine, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing.

Critère d'inclusion

• Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities,Adult Acute Myeloid Leukemia With Del(5q),Adult Acute Myeloid Leukemia With Inv(16)(p13;q22),Adult Acute Myeloid Leukemia With t(15;17)(q22;q12),Adult Acute Myeloid Leukemia With t(16;16)(p13;q22),Adult Acute Myeloid Leukemia With t(8;21)(q22;q22),Childhood Myelodysplastic Syndromes,Chronic myelomonocytic leukemia,Previously Treated Myelodysplastic Syndromes,Recurrent Adult Acute Myeloid Leukemia,Recurrent Childhood Acute Myeloid Leukemia,Secondary Myelodysplastic Syndromes

Liens

• ictrp
• nct